findmyKOL
Clinical trialNCT07147231RecruitingPhase 1/PHASE2Interventional

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

SponsorNational Cancer Institute (NCI)Enrollment86Metastatic Colorectal AdenocarcinomaRefractory Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Unresectable Colorectal Adenocarcinoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Emory Saint Joseph'S Hospital

    Atlanta, Georgia, United States

    Olumide B. Gbolahan
    Recruiting
  • Emory University Hospital Midtown

    Atlanta, Georgia, United States

    Olumide B. Gbolahan
    Recruiting
  • Emory University Hospital/winship Cancer Institute

    Atlanta, Georgia, United States

    Olumide B. Gbolahan
    Recruiting
  • Johns Hopkins University/sidney Kimmel Cancer Center

    Baltimore, Maryland, United States

    Eric Christenson
    Recruiting
  • University of Maryland/greenebaum Cancer Center

    Baltimore, Maryland, United States

    Daniel Shu
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
21 Dec 2026
Primary completion
30 Sept 2027
Completion
30 Sept 2027
Last update posted
29 Jun 2026
Registered enrollment
86
Registry id
NCT07147231
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.